Dapure 10 Tablet
Marketer
Ampure Pharmaceutical LLP
Salt Composition
Dapagliflozin (10mg)
Overview Dapure 10 Tablet
TenDap tablets are indicated, either singularly or in conjunction with other medications, for the management of type 2 diabetes. They facilitate the regulation of elevated blood glucose characteristic of this condition, thereby mitigating the risk of associated severe complications and contributing to cardiovascular health preservation. TenDap tablets may be administered with or without food, at any time, but consistent daily timing is recommended. Dosage is determined by your physician; discontinuation requires their consultation, as abrupt cessation can lead to hyperglycemia and serious consequences such as renal impairment and vision loss. This medication forms one component of a comprehensive treatment plan incorporating a balanced diet, regular physical activity, and, if necessary, weight management, as directed by your doctor. Frequently reported side effects encompass vaginal candidiasis, nasopharyngitis, and urinary tract infections. Dehydration is a potential adverse effect; ample fluid intake is therefore advised. Practicing good hygiene can help minimize the likelihood of genital fungal infections. Prior to initiating treatment, disclose any kidney or liver dysfunction, urinary tract infections, or diuretic use to your physician. Similarly, pregnant or lactating individuals should seek medical advice. Limit alcohol consumption during treatment, as it may augment the probability of side effects. Regular blood glucose monitoring is crucial during treatment.
Primary Ingredients of Dapure 10 Tablet
No information provided. A rephrased text cannot be generated.
Uses of Dapure 10 Tablet
Managing type 2 diabetes
Major Benefits of Dapure 10 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapure 10 Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Dapure 10 Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapure 10 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or splitting it. Dapure 10 Tablets can be consumed with or without food, but consistent timing is recommended.
How Dapure 10 Tablet works:
Dapure 10 tablets are used to manage diabetes. This medication facilitates the excretion of surplus glucose via the urinary system.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Dapure 10 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Dapure 10 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Dapure 10 Tablet use are likely incompatible. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Individuals with kidney impairment should likely abstain from Dapure 10 Tablets due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Dapure 10 Tablet presents no contraindications for use in individuals with hepatic impairment. No dosage modification is advised for this patient population.
What if you forget to take Dapure 10 Tablet :
Should you forget a Dapure 10 Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dapure 10 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Behavior Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
3,018 People bought this recently